$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 67.63 | 26,200 | 1,771,906 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 30.74 | 10,000 | 307,400 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | D | 23.85 | 1,000 | 23,850 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 57.50 | 775 | 44,563 | 910 | 1.7 K to 910 (-45.99 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Sell | D | 57.50 | 17,225 | 990,438 | 1,685 | 18.9 K to 1.7 K (-91.09 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Sell | U | 57.50 | 19,414 | 1,116,305 | 18,910 | 38.3 K to 18.9 K (-50.66 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Option Exercise | D | 35.40 | 33,000 | 1,168,200 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Option Exercise | D | 39.77 | 125,000 | 4,971,250 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Sell | D | 57.50 | 20,375 | 1,171,563 | 0 | 20.4 K to 0 (-100.00 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Sell | U | 57.50 | 1,674 | 96,255 | 20,375 | 22 K to 20.4 K (-7.59 %) |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Option Exercise | D | 35.40 | 9,000 | 318,600 | 0 | |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Option Exercise | D | 33.62 | 2,580 | 86,740 | 0 | |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Option Exercise | D | 38.13 | 18,900 | 720,657 | 0 | |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Sell | D | 57.50 | 4,975 | 286,063 | 16 | 5 K to 16 (-99.68 %) |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Sell | U | 57.50 | 445 | 25,588 | 4,991 | 5.4 K to 5 K (-8.19 %) |
Jun 03 2010 | OSIP | OSI PHARMACEUTICAL ... | Davies Angela M. | Sr. VP and CMO, Onc ... | Sell | S | 57.44 | 298 | 17,117 | 5,436 | 5.7 K to 5.4 K (-5.20 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 67.63 | 13,900 | 940,057 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 35.40 | 20,000 | 708,000 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 33.62 | 36,000 | 1,210,320 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 47.29 | 16,500 | 780,285 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 37.74 | 10,000 | 377,400 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | D | 23.83 | 3,001 | 71,514 | 0 | |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Sell | D | 57.50 | 14,775 | 849,563 | 0 | 14.8 K to 0 (-100.00 %) |
Jun 07 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Sell | U | 57.50 | 4,326 | 248,745 | 14,775 | 19.1 K to 14.8 K (-22.65 %) |
May 04 2010 | OSIP | OSI PHARMACEUTICAL ... | Epstein David M. | Sr. VP and CSO, Onc ... | Payment of Exercise | F | 58.67 | 906 | 53,155 | 13,340 | 14.2 K to 13.3 K (-6.36 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | M | 23.83 | 8,499 | 202,531 | 3,001 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | M | 38.01 | 7,370 | 280,134 | 0 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Sell | S | 55.20 | 15,869 | 875,969 | 19,101 | 35 K to 19.1 K (-45.38 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Buy | M | 23.83 | 8,499 | 202,531 | 34,970 | 26.5 K to 35 K (+32.11 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Buy | M | 38.01 | 7,370 | 280,134 | 26,471 | 19.1 K to 26.5 K (+38.58 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 23.25 | 66,000 | 1,534,500 | 34,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 55.17 | 66,000 | 3,641,220 | 158,265 | 224.3 K to 158.3 K (-29.43 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 23.25 | 66,000 | 1,534,500 | 224,265 | 158.3 K to 224.3 K (+41.70 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | M | 35.88 | 20,000 | 717,500 | 20,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | S | 55.11 | 20,000 | 1,102,200 | 27,366 | 47.4 K to 27.4 K (-42.22 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Buy | M | 35.88 | 20,000 | 717,500 | 47,366 | 27.4 K to 47.4 K (+73.08 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | M | 29.77 | 13,000 | 387,010 | 5,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | M | 35.10 | 15,200 | 533,520 | 0 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Sell | S | 55.20 | 29,200 | 1,611,840 | 30,623 | 59.8 K to 30.6 K (-48.81 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Buy | M | 29.77 | 13,000 | 387,010 | 59,823 | 46.8 K to 59.8 K (+27.76 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Buy | M | 35.10 | 15,200 | 533,520 | 46,823 | 31.6 K to 46.8 K (+48.07 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | M | 30.74 | 18,472 | 567,829 | 10,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | M | 23.85 | 24,761 | 590,550 | 1,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Sell | S | 55.37 | 43,233 | 2,393,811 | 38,324 | 81.6 K to 38.3 K (-53.01 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Buy | M | 30.74 | 18,472 | 567,829 | 81,557 | 63.1 K to 81.6 K (+29.28 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Buy | M | 23.85 | 24,761 | 590,550 | 63,085 | 38.3 K to 63.1 K (+64.61 %) |
Feb 02 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 34.00 | 1,000 | 34,000 | 5,000 | 4 K to 5 K (+25.00 %) |
Jan 26 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 34.00 | 1,000 | 34,000 | 4,000 | 3 K to 4 K (+33.33 %) |
Jan 25 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 34.00 | 1,000 | 34,000 | 3,000 | 2 K to 3 K (+50.00 %) |
Jan 12 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 32.09 | 1,000 | 32,090 | 2,000 | 1,000 to 2 K (+100.00 %) |
Jan 05 2010 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 31.13 | 1,000 | 31,130 | 1,000 | 0 to 1,000 |
Jan 04 2010 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Payment of Exercise | F | 31.06 | 1,451 | 45,068 | 22,049 | 23.5 K to 22 K (-6.17 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 35.40 | 135,000 | 4,779,000 | 135,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 32.89 | 2,968 | 97,618 | 158,265 | 161.2 K to 158.3 K (-1.84 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 0.00 | 35,000 | 0 | 161,233 | 126.2 K to 161.2 K (+27.73 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Payment of Exercise | F | 32.89 | 502 | 16,511 | 14,402 | 14.9 K to 14.4 K (-3.37 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Grant | A | 0.00 | 6,700 | 0 | 14,904 | 8.2 K to 14.9 K (+81.67 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 32.89 | 926 | 30,456 | 38,324 | 39.3 K to 38.3 K (-2.36 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Grant | A | 0.00 | 6,700 | 0 | 39,250 | 32.6 K to 39.3 K (+20.58 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 32.89 | 949 | 31,213 | 31,623 | 32.6 K to 31.6 K (-2.91 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Grant | A | 0.00 | 6,700 | 0 | 32,572 | 25.9 K to 32.6 K (+25.90 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | A | 35.40 | 15,000 | 531,000 | 15,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 32.89 | 622 | 20,458 | 27,366 | 28 K to 27.4 K (-2.22 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Grant | A | 0.00 | 5,000 | 0 | 27,988 | 23 K to 28 K (+21.75 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Option Exercise | A | 35.40 | 24,000 | 849,600 | 24,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Payment of Exercise | F | 32.89 | 1,027 | 33,778 | 40,368 | 41.4 K to 40.4 K (-2.48 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Grant | A | 0.00 | 8,000 | 0 | 41,395 | 33.4 K to 41.4 K (+23.96 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Option Exercise | A | 35.40 | 33,000 | 1,168,200 | 33,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Grant | A | 0.00 | 11,000 | 0 | 23,500 | 12.5 K to 23.5 K (+88.00 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Payment of Exercise | F | 32.89 | 562 | 18,484 | 19,101 | 19.7 K to 19.1 K (-2.86 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Grant | A | 0.00 | 6,700 | 0 | 19,663 | 13 K to 19.7 K (+51.69 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Payment of Exercise | F | 34.75 | 309 | 10,738 | 12,963 | 13.3 K to 13 K (-2.33 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, Human Resou ... | Payment of Exercise | F | 34.75 | 515 | 17,896 | 13,272 | 13.8 K to 13.3 K (-3.74 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 34.75 | 1,487 | 51,673 | 126,233 | 127.7 K to 126.2 K (-1.16 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 34.75 | 2,493 | 86,632 | 127,720 | 130.2 K to 127.7 K (-1.91 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 34.75 | 795 | 27,626 | 32,550 | 33.3 K to 32.6 K (-2.38 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 34.75 | 567 | 19,703 | 33,345 | 33.9 K to 33.3 K (-1.67 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 34.75 | 815 | 28,321 | 25,872 | 26.7 K to 25.9 K (-3.05 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 34.75 | 892 | 30,997 | 26,687 | 27.6 K to 26.7 K (-3.23 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Payment of Exercise | F | 34.75 | 291 | 10,112 | 33,672 | 34 K to 33.7 K (-0.86 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharmaceut. & ... | Payment of Exercise | F | 34.75 | 570 | 19,808 | 33,963 | 34.5 K to 34 K (-1.65 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Payment of Exercise | F | 34.75 | 304 | 10,564 | 8,204 | 8.5 K to 8.2 K (-3.57 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | Rachman Jonathan | Sr VP, Diabetes/Obe ... | Payment of Exercise | F | 34.75 | 452 | 15,707 | 8,508 | 9 K to 8.5 K (-5.04 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 34.75 | 519 | 18,035 | 22,988 | 23.5 K to 23 K (-2.21 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 34.75 | 570 | 19,808 | 23,507 | 24.1 K to 23.5 K (-2.37 %) |
Dec 08 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 33.68 | 75 | 2,526 | 130,213 | 130.3 K to 130.2 K (-0.06 %) |
Dec 08 2009 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 33.68 | 200 | 6,736 | 130,288 | 130.1 K to 130.3 K (+0.15 %) |
Jul 16 2009 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 30.38 | 519 | 15,767 | 24,077 | 24.6 K to 24.1 K (-2.11 %) |
Jul 16 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 30.38 | 628 | 19,079 | 33,912 | 34.5 K to 33.9 K (-1.82 %) |
Jul 16 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | EVP, Pharm. Dev & M ... | Payment of Exercise | F | 30.38 | 389 | 11,818 | 34,305 | 34.7 K to 34.3 K (-1.12 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 2,500 | 0 | 18,323 | 15.8 K to 18.3 K (+15.80 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 2,500 | 0 | 11,490 | 9 K to 11.5 K (+27.81 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Grant | A | 0.00 | 2,500 | 0 | 24,000 | 21.5 K to 24 K (+11.63 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 0.00 | 2,500 | 0 | 10,467 | 8 K to 10.5 K (+31.38 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 2,500 | 0 | 86,251 | 83.8 K to 86.3 K (+2.99 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | A | 28.65 | 3,000 | 85,950 | 3,000 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 1,500 | 0 | 11,500 | 10 K to 11.5 K (+15.00 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 2,500 | 0 | 14,000 | 11.5 K to 14 K (+21.74 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 28.65 | 10,000 | 286,500 | 10,000 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 4,000 | 0 | 29,886 | 25.9 K to 29.9 K (+15.45 %) |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | A | 28.65 | 7,500 | 214,875 | 7,500 | |
Jun 19 2009 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Grant | A | 0.00 | 2,500 | 0 | 14,000 | 11.5 K to 14 K (+21.74 %) |
Mar 18 2009 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 38.63 | 750 | 28,973 | 15,823 | 16.6 K to 15.8 K (-4.53 %) |
Feb 17 2009 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 40.24 | 750 | 30,180 | 16,573 | 17.3 K to 16.6 K (-4.33 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 15.02 | 7,500 | 112,650 | 2,500 | |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 2,500 | 50,783 | 0 | |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.10 | 10,000 | 420,954 | 16,537 | 26.5 K to 16.5 K (-37.68 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 15.02 | 7,500 | 112,650 | 26,537 | 19 K to 26.5 K (+39.40 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 2,500 | 50,783 | 19,037 | 16.5 K to 19 K (+15.12 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | M | 29.77 | 2,000 | 59,540 | 18,000 | |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 41.25 | 2,000 | 82,500 | 27,579 | 29.6 K to 27.6 K (-6.76 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Buy | M | 29.77 | 2,000 | 59,540 | 29,579 | 27.6 K to 29.6 K (+7.25 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 3,401 | 73,292 | 2,300 | |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 41.25 | 3,401 | 140,291 | 34,303 | 37.7 K to 34.3 K (-9.02 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 3,401 | 73,292 | 37,704 | 34.3 K to 37.7 K (+9.91 %) |
Jan 16 2009 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 37.68 | 750 | 28,260 | 17,323 | 18.1 K to 17.3 K (-4.15 %) |
Jan 07 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 49 | 1,056 | 5,701 | |
Jan 07 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 40.00 | 49 | 1,960 | 34,303 | 34.4 K to 34.3 K (-0.14 %) |
Jan 07 2009 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 49 | 1,056 | 34,352 | 34.3 K to 34.4 K (+0.14 %) |
Jan 05 2009 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Option Exercise | A | 39.77 | 125,000 | 4,971,250 | 125,000 | |
Jan 05 2009 | OSIP | OSI PHARMACEUTICAL ... | Legault Pierre | Exec. VP, CFO & Tre ... | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 33.62 | 48,000 | 1,613,760 | 48,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 7,800 | 0 | 34,540 | 26.7 K to 34.5 K (+29.17 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 33.62 | 48,000 | 1,613,760 | 48,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 7,800 | 0 | 27,579 | 19.8 K to 27.6 K (+39.44 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | A | 33.62 | 60,000 | 2,017,200 | 60,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Grant | A | 0.00 | 10,000 | 0 | 34,140 | 24.1 K to 34.1 K (+41.43 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 33.62 | 135,000 | 4,538,700 | 135,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 130,088 | 105.1 K to 130.1 K (+23.79 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, HR & Traini ... | Option Exercise | A | 33.62 | 36,000 | 1,210,320 | 36,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, HR & Traini ... | Grant | A | 0.00 | 6,000 | 0 | 13,787 | 7.8 K to 13.8 K (+77.05 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | A | 33.62 | 36,000 | 1,210,320 | 36,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Grant | A | 0.00 | 6,000 | 0 | 24,596 | 18.6 K to 24.6 K (+32.27 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, HR & Traini ... | Payment of Exercise | F | 33.39 | 279 | 9,316 | 7,787 | 8.1 K to 7.8 K (-3.46 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr. VP, HR & Traini ... | Payment of Exercise | F | 33.39 | 465 | 15,526 | 8,066 | 8.5 K to 8.1 K (-5.45 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 33.39 | 1,058 | 35,327 | 105,088 | 106.1 K to 105.1 K (-1.00 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 33.39 | 1,775 | 59,267 | 106,146 | 107.9 K to 106.1 K (-1.64 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 33.39 | 473 | 15,793 | 18,596 | 19.1 K to 18.6 K (-2.48 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 33.39 | 520 | 17,363 | 19,069 | 19.6 K to 19.1 K (-2.65 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 33.15 | 750 | 24,863 | 18,073 | 18.8 K to 18.1 K (-3.98 %) |